The largest database of trusted experimental protocols

161 protocols using nupage novex bis tris gel

1

Western Blot Analysis of SVD Antigens

Check if the same lab product or an alternative is used in the 5 most similar protocols
SVD-VLP, mock-infected Sf9 cell lysates, and SVDV grown in ST cells prepared in the same manner as SVD-VLP were separated with 10% NuPAGE Novex Bis-Tris gels (Invitrogen) followed by protein transfer to nitrocellulose membranes using a iBlot gel transfer device (Invitrogen). Membranes were incubated in PBS-T with 5% skim milk at room temperature for 1 h then blotted with anti-mouse SVD serum (1:500) in blocking buffer overnight at 4℃, followed by incubation with HRP-conjugated anti-mouse antibody (1:2,000; Jackson ImmunoResearch Laboratories) for 1 h at room temperature. Blots were developed by using 3, 3′-diaminobenzidine (Sigma-Aldrich).
+ Open protocol
+ Expand
2

Western Blot Protein Separation and Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were washed twice with PBS, and lysed with 95 °C SDS-sample buffer containing 4% β-mecapto-ethanol. Samples were boiled at 95 °C for 4 min to denature proteins. Proteins were separated on 4–12% NuPAGE Novex Bis-Tris gels (Invitrogen), transferred to Immobilon-PVDF transfer membranes (Millipore Corp., Billerica, MA) and subsequently blocked with 2.5% (w/v) BSA in Tris-buffered saline with Tween 20 for 60 min. The immunoblots were analysed using primary antibodies incubated overnight at 4 °C and secondary antibodies linked to horseradish peroxidase (HRP) (GE Healthcare, UK), after each step immunoblots were washed 6 × with Tris-buffered saline with Tween 20. Signals were visualized by enhanced chemiluminescence and light sensitive films (GE Healthcare, UK). The full blots of all immunoblots presented in the study are shown in Supplementary Fig. 8.
+ Open protocol
+ Expand
3

Protein Extraction and Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
For total protein extracts, 8 M urea lysis buffer was used (8 M urea, 0.5% [v:v] Triton X-100 [Sigma-Aldrich, X100], DTT [100 mM], Complete® protease inhibitor [PI; Roche, 11873580001]), long with phosphatase inhibitor cocktail (PIC) 2 and 3 (Sigma, P5726 and P0044). Protein concentration was determined by Bio-Rad protein assay (Bio-Rad 500–0006). Proteins (50 µg) were separated using NuPAGE® Novex® Bis-Tris Gels (Invitrogen, NP0322, NP0321, WG1403, WG1402A), transferred to nitrocellulose membranes using Invitrogen's iBlot system. Bound antibodies were imaged using appropriate near-infrared (NIR) dye conjugates (Li-Cor) and an Odyssey NIR scanner (Li-Cor Biosciences) or using HRP-linked secondary antibodies (Dako) and SuperSignal West Femto substrate (Pierce, 34096) with a Li-Cor Odyssey Fc System. Image studio 3.1 was used for quantification. For statistical assessment, mean intensity values were used, while bar graphs of quantifications show fold changes.
+ Open protocol
+ Expand
4

Protein Fractionation and Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The total proteins extracted from HEp-2 cells were fractionated in a DS-Sepharose column with a BioLogic Duo-Flow system (Bio-Rad). About 40 mg of proteins in 40 mL of 10 mM phosphate buffer (pH 7.4; buffer A) were loaded into the DS-Sepharose column at a rate of 1 mL/min. After loading, the column was washed with 60 mL of buffer A to remove excess and non-binding proteins, followed by eluting with 40 mL of 0.2 M NaCl in buffer A to further remove very weakly binding proteins. Proteins with low to high DS-affinity were eluted with sequential 40-mL step gradients of 0.4 M, 0.6 M, and 1.0 M NaCl in buffer A. Fractions were desalted and concentrated to 0.5 mL with 5-kDa cut-off Vivaspin 20 centrifugal filters (Sartorius). The protein concentration of each fraction was measured. Fractionated proteins were further separated by 1-D SDS PAGE using 4–12% NuPAGE Novex Bis–Tris gels with MES running buffer (Invitrogen). Each gel lane was divided into three sections and subjected to protein sequencing.
+ Open protocol
+ Expand
5

Proteomic Analysis of GAL4-PCGFs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins from GAL4-PCGFs purification were separated by SDS–PAGE, using 4%–12% NuPAGE Novex Bis–Tris gels (Invitrogen) and NuPAGE MES SDS running buffer (Invitrogen) and then stained with Coomassie Blue using InstantBlue Comassie (Expedeon). Bands from gel were cut and digested with trypsin (Promega) and incubated for 16 h at 37°C for protein digestion. Then, peptide extraction was carried out and the resulting peptides mixture were combined, reduced in volume in a vacuum concentrator, desalted and concentrated using StageTip (Proxeon Biosystems) columns, washed with 30 μL of 0,1% Formic acid (FA) and finally eluted with 40 μL of 80% MeCN in 0,1% FA. The samples were concentrated in vacuum concentrator (Eppendorf concentrator 5301) for 5 min and peptides were dissolved in 7 μL of 0,1% FA. Approximately 5 μL of purified peptide mixture were analyzed on a LC–ESI–MS-MS Q Exactive HF hybrid quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific). Full scan MS spectra were acquired in a range of m/z 300–1800.
+ Open protocol
+ Expand
6

Saliva Protein Profiling by SDS-PAGE

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sodium dodecyl sulfate PAGE (SDS-PAGE) was carried out on saliva samples. Saliva samples were prepared for electrophoresis by dilution 4 × concentration LDS sample buffer (Invitrogen) with the addition of 0.5M DTT (Sigma) to the sample-buffer solution and then boiled for 3 min. Pre-cast 4–12% NuPAGE Novex Bis-Tris gels (Invitrogen) were assembled in a XCell vertical electrophoresis unit (Invitrogen) with MES running buffer (Invitrogen). Samples were loaded with equal protein concentration and electrophoresed for 32 min at 125 mA and 200 V (constant). Molecular masses were determined by comparison with SeeBlue Plus2 standard proteins (Thermo Scientific).
+ Open protocol
+ Expand
7

Western Blot for WNT7b and CDK6

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell pellets were lysed in RIPA buffer and the lysates were cleared by centrifugation at 20,800×g for 10 min. Proteins were separated on 4–12% NuPAGE Novex Bis-Tris gels (Invitrogen), transferred to nitrocellulose (Schleicher and Schuel) or Immobilon (Millipore) membrane and probed with antibodies. Immuno-complexes were visualized by enhanced chemo-illuminescence (Pierce 34080) using goat anti-mouse (AMI3404, Biosource) or goat anti-rabbit (ALI0404, Biosource) antibodies coupled to horseradish peroxidase. The primary antibodies used were: WNT7b: Abcam (ab94915); CDK6: Thermo (AHZ0232).
+ Open protocol
+ Expand
8

Western Blot Analysis of Esrrβ Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
For western blot analysis, samples were loaded on 4–12% NuPAGE Novex Bis-Tris gels (Invitrogen, Carlsbad, CA), separated, and blotted onto polyvinylidene fluoride (PVDF) membrane (Westran S, Whatman Inc., Sanford, ME). For immunodetection, membranes were blocked in 5% skimmed milk powder, and anti-Esrrβ polyclonal antibody (1:500; Abcam, Cambridge, MA; ab19331) was applied overnight at 4 °C. The horseradish-peroxidase-coupled secondary antibodies (goat anti-rabbit-HRP 1:5000; Sigma-Aldrich, St. Louis, MO; A0545) were visualized using an enhanced chemiluminescence (ECL) detection system (GE Healthcare Amersham, Freiburg, Germany). To ensure that immunoreactivity was derived from equal protein amounts of homogenates, staining with rabbit anti-β-actin polyclonal antibody (1:300; Sigma-Aldrich; A2066) was conducted. Densitometric measurement was performed using the ImageJ 1.46o software (National Institutes of Health, Bethesda, MD).
+ Open protocol
+ Expand
9

Kidney Protein Fractionation and Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Kidney protein-extracts (20 μg aliquots) were fractionated by SDS-PAGE on 4–12% NuPAGE® Novex® Bis-Tris gels (Invitrogen, Grand Island, NY). Separated proteins were transferred to nitrocellulose membranes (Millipore, Billerica, MA, USA) at 300 mA for 90 min at room temperature. Membranes were blocked in TBS-T (20 mM Tris pH 7.5, 500 mM NaCl, 0.1% Tween 20) supplemented with 5% non-fat dry milk (Bio-Rad) for 1 h at room temperature. Blots were probed with the following primary antibodies: goat anti-Aminopeptidase N (AP-N), goat anti-Meprin A subunit alpha (Mep-1) and rabbit anti-glutamyl aminopeptidase (AP-A) (R&D system, 1:1000), rabbit anti-fatty acid binding protein heart type (FABPH) (1:200, Gene Tax), rabbit anti-11-fold increase in NADH dehydrogenase [ubiquinone] 1 beta sub complex subunit 9 (CI-B22) (1:500, Gene Tax) and mouse anti-vinculin (1:2000, Cell Signaling) with the corresponding horseradish peroxidase-conjugated secondary antibody (1:5000–1:20,000 dilution). Blots were processed using an ECL detection kit (GE Life, Pittsburgh, PA) and exposed to X-ray films. For quantification, films were scanned using a Bio-Rad GS-800 calibrated densitometer running Quantity One software (Bio-Rad). Optical density of each specific band was analyzed using Image J Software.
+ Open protocol
+ Expand
10

Quantitative Insulin Immunoblotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins (3 mg/lane by BCA protein assay) were separated on 4–12% NuPAGE Novex Bis-Tris gels (Invitrogen), electrotransferred to nitrocellulose (Bio-Rad), and immunoblotted with guinea pig anti-insulin (Linco/Millipore) and mouse anti-tubulin (Sigma). Horseradish peroxidase-conjugated secondary antibodies were from Jackson ImmunoResearch with proteins visualized by enhanced chemiluminescence (ECL, Millipore).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!